tirzepatide vs. semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs Semaglutide | Best

10.3389/fpubh.2024.1277113 Summary Keywords adolescents, clinical applications, GLP-1 receptor agonists (GLP-1 RAs), pediatric obesity, weight loss Citation Wen H (2026) Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity

Hey, Thanks for giving this information to us.

Additionally, many POTS patients rely on caffeine to constrict blood vessels and improve cerebral blood flow, but struggle with caffeine-induced tachycardia and jitters

Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al

You're simultaneously protecting revenue , optimizing staffing efficiency , and boosting patient satisfaction

doi: 10.1177/2040622315609312 [DOI] [PMC free article] [PubMed] [Google Scholar] 59